Cargando…
Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women
CONTEXT: Studies suggest that menopausal hormone therapy (MHT) prevents type 2 diabetes (T2D). The combination of conjugated estrogens (CE) with the selective estrogen receptor modulator bazedoxifene (BZA) is an MHT that improves obesity and T2D in preclinical models of menopausal metabolic syndrome...
Autores principales: | Lovre, Dragana, Peacock, Erin, Katalenich, Bonnie, Moreau, Cynthia, Xu, Beibei, Tate, Chandra, Utzschneider, Kristina M, Gautier, Jean-François, Fonseca, Vivian, Mauvais-Jarvis, Franck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676076/ https://www.ncbi.nlm.nih.gov/pubmed/31384719 http://dx.doi.org/10.1210/js.2019-00074 |
Ejemplares similares
-
MON-160 Effect Of The Combination Conjugated Estrogens And Bazedoxifene On Glucose Homeostasis In Obese Postmenopausal Women: A Placebo-controlled Randomized Pilot Trial
por: Lovre, Dragana, et al.
Publicado: (2019) -
88116 Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women
por: Marlatt, Kara, et al.
Publicado: (2021) -
SUN-582 Effect of the Combination of Conjugated Estrogens and Bazedoxifene on Muscle and Serum Lipidome in Obese Postmenopausal Women: A Placebo-Controlled Randomized Pilot Trial
por: Lovre, Dragana, et al.
Publicado: (2020) -
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017) -
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012)